View in EDS HTML Full Text PDF Full Text

Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Saved in:
Bibliographic Details
Title: Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.
Authors: Dunn, Amy1 (AUTHOR) amy.dunn2@nationwidechildrens.org, Dargaud, Yesim2 (AUTHOR), Abajas, Yasmina3 (AUTHOR), Carcao, Manuel4 (AUTHOR), Castaman, Giancarlo5 (AUTHOR), Giermasz, Adam6 (AUTHOR), Hermans, Cédric7 (AUTHOR), Jiménez‐Yuste, Victor8 (AUTHOR), Lewandowska, Magdalena9 (AUTHOR), Mahlangu, Johnny10 (AUTHOR), Meeks, Shannon11 (AUTHOR), Miesbach, Wolfgang12 (AUTHOR), Recht, Michael13 (AUTHOR), Salinas, Vanessa14 (AUTHOR), Chrisentery‐Singleton, Tammuella15 (AUTHOR), Bonzo, Daniel16 (AUTHOR), Mitchell, Ian S.17 (AUTHOR), Wilkinson, Thomas A.18 (AUTHOR), Young, Guy19,20 (AUTHOR)
Source: Haemophilia. Jan2025, Vol. 31 Issue 1, p78-86. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13518216
DOI:10.1111/hae.15109